PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond

被引：261

作者：

Fattahi, Sadegh ^{[1
,2
,3
]}

Amjadi-Moheb, Fatemeh ^{[4
]}

Tabaripour, Reza ^{[5
]}

Ashrafi, Gholam Hossein ^{[6
]}

Akhavan-Niaki, Haleh ^{[4
]}

机构：

[1] Babol Univ Med Sci, Student Res Comm, Babol, Iran

[2] Babol Univ Med Sci, Hlth Res Inst, Cellular & Mol Biol Res Ctr, Babol, Iran

[3] Pasteur Inst, North Res Ctr, Amol, Iran

[4] Babol Univ Med Sci, Dept Genet, Fac Med, Babol, Iran

[5] Islamic Azad Univ, Dept Cellular & Mol Biol, Babol Branch, Babol, Iran

[6] Kingston Univ London, Sch Life Sci Pharm & Chem, SEC Fac, Canc Theme, London KT12EE, England

来源：

LIFE SCIENCES | 2020年 / 262卷

关键词：

PI3K/AKT/mTOR pathway; Epigenetic modulation; Gastric cancer; Chemoresistance; Non-coding RNAs; Targeted therapy; PROMOTES CISPLATIN RESISTANCE; INHIBITS CELL-PROLIFERATION; ABERRANT DNA METHYLATION; HUMAN OVARIAN-CANCER; NF-KAPPA-B; AKT INHIBITOR; UP-REGULATION; PHOSPHOINOSITIDE; 3-KINASES; MESENCHYMAL TRANSITION; SCAFFOLDING FUNCTION;

D O I：

10.1016/j.lfs.2020.118513

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

PI3K/AKT/mTOR pathway is one of the most important signaling pathways involved in normal cellular processes. Its aberrant activation modulates autophagy, epithelial-mesenchymal transition, apoptosis, chemoresistance, and metastasis in many human cancers. Emerging evidence demonstrates that some infections as well as epigenetic regulatory mechanisms can control PI3K/AKT/mTOR signaling pathway. In this review, we focused on the role of this pathway in gastric cancer development, prognosis, and metastasis, with an emphasis on epigenetic alterations including DNA methylation, histone modifications, and post-transcriptional modulations through non-coding RNAs fluctuations as well as H. pylori and Epstein-Barr virus infections. Finally, we reviewed different molecular targets and therapeutic agents in clinical trials as a potential strategy for gastric cancer treatment through the PI3K/AKT/mTOR pathway.

引用

页数：16

共 50 条

[41] The PI3K/AKT/mTOR interactive pathway
Ersahin, Tulin
Tuncbag, Nurcan
Cetin-Atalay, Rengul
MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1946 - 1954
[42] PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy
Manfredi, Gloria Irene
Dicitore, Alessandra
Gaudenzi, Germano
Caraglia, Michele
Persani, Luca
Vitale, Giovanni
ENDOCRINE, 2015, 48 (02) : 363 - 370
[43] Demethylase FTO enhances the PI3K/Akt signaling to promote gastric cancer malignancy
Zhu, Yuxuan
Yang, Jing
Li, Yongxiang
Xu, Jiegou
Fang, Zheng
MEDICAL ONCOLOGY, 2023, 40 (05)
[44] TLR4 inhibited autophagy by modulating PI3K/AKT/mTOR signaling pathway in Gastric cancer cell lines
Zhang, Qian
Dan, Jun
Meng, Shuang
Li, Yingjie
Li, Jing
GENE, 2023, 876
[45] Demethylase FTO enhances the PI3K/Akt signaling to promote gastric cancer malignancy
Yuxuan Zhu
Jing Yang
Yongxiang Li
Jiegou Xu
Zheng Fang
Medical Oncology, 40
[46] PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis
Chen, Qiao Yi
Costa, Max
MOLECULAR PHARMACOLOGY, 2018, 94 (01) : 784 - 792
[47] The Cardioprotection of the Insulin-Mediated PI3K/Akt/mTOR Signaling Pathway
Yao, Hong
Han, Xiangyang
Han, Xiuzhen
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (06) : 433 - 442
[48] Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Kawauchi, Kiyotaka
Ogasawara, Toshie
Yasuyama, Masako
Otsuka, Kuniaki
Yamada, Osamu
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (09) : 1024 - 1038
[49] PI3K/Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes
Wu, Xiaofeng
Kihara, Takeshi
Akaike, Akinori
Niidome, Tetsuhiro
Sugimoto, Hachiro
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 393 (03) : 514 - 518
[50] Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC
Heavey, Susan
O'Byrne, Kenneth J.
Gately, Kathy
CANCER TREATMENT REVIEWS, 2014, 40 (03) : 445 - 456

← 1 2 3 4 5 →